MPO and irritable bowel syndrome: We have extended our work on evaluating myeloperoxidase in feces as a biomarker of endoscopic disease severity in IBD by developing methods to measure its enzyme activity.3 We found that the enzyme activity of myeloperoxidase is linked to endoscopic gut inflammation in IBD.